Plain-English translation of NCT06477146 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This clinical trial is testing milk thistle, an herbal supplement, as a potential treatment for pediatric non-alcoholic fatty liver disease (NAFLD)โa condition where fat builds up in the liver without being caused by alcohol. The study recognizes that sticking to diet and exercise changes can be hard, so researchers want to see if this medication might offer an easier way to improve liver health. Half of the participants will receive milk thistle capsules, and half will receive a placebo (a dummy pill), over 12 weeks.
Fatty liver disease is becoming more common in young people in the United States and is expected to be the leading reason adults need liver transplants within the next 20 years. Since lifestyle changes alone can be difficult for families to maintain consistently, this study is exploring whether the medication could be an effective and easier-to-follow alternative treatment.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you enroll, you will be randomly assigned to receive either milk thistle capsules or a placebo capsule by mouth, dosed based on your weight, once or twice daily for 12 weeks. You will likely have clinic visits to check your health, have blood work done to measure your liver function, and possibly have imaging scans to see if your liver improves. The study team will track how well the treatment works and watch for any side effects.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
United States